Cargando…
Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis
Lymphocyte costimulation plays a central role in immunology, inflammation, and immunotherapy. The inducible T cell costimulator (ICOS) is expressed on T cells following peptide: MHC engagement with CD28 costimulation. The interaction of ICOS with its sole ligand, the inducible T cell costimulatory l...
Autores principales: | O'Dwyer, Ronan, Kovaleva, Marina, Zhang, Jiquan, Steven, John, Cummins, Emma, Luxenberg, Deborah, Darmanin-Sheehan, Alfredo, Carvalho, Miguel F., Whitters, Matthew, Saunders, Kenneth, Barelle, Caroline J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207862/ https://www.ncbi.nlm.nih.gov/pubmed/30417018 http://dx.doi.org/10.1155/2018/4089459 |
Ejemplares similares
-
Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis
por: Kovaleva, Marina, et al.
Publicado: (2017) -
Inducible costimulator ligand (ICOSL) on CD19(+) B cells is involved in immunopathological damage of rheumatoid arthritis (RA)
por: Ding, Sisi, et al.
Publicado: (2022) -
Loss of human ICOSL results in combined immunodeficiency
por: Roussel, Lucie, et al.
Publicado: (2018) -
Osteopontin binds ICOSL promoting tumor metastasis
por: Raineri, Davide, et al.
Publicado: (2020) -
The ICOS–ICOSL pathway tunes thymic selection
por: Dong, Mengqi, et al.
Publicado: (2022)